Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT03392558
Status:
COMPLETED
Last Update Posted:
2018-06-21
First Post:
2017-12-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
Sponsor:
Burt's Bees Inc.
Organization:
Study Overview
Official Title:
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates a nature-based sensitive skin regimen (NBSSR), as a suitable adjunct topical application to prescription medication when administered daily over the course of four weeks, in moderate to severe rosacea in comparison to the control regimen (CR).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: